[
    [
        {
            "time": "2023-10-18",
            "original_text": "沃森生物mRNA新冠疫苗启动海外三期研究，称具里程碑意义",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA",
                    "新冠疫苗",
                    "海外三期研究",
                    "里程碑"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物mRNA新冠疫苗启动海外三期研究，称具里程碑意义",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "沃森生物：公司各产品生产、批签发、销售和国际出口业务均正常开展",
            "features": {
                "keywords": [
                    "沃森生物",
                    "生产",
                    "批签发",
                    "销售",
                    "国际出口"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：公司各产品生产、批签发、销售和国际出口业务均正常开展",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "沃森生物：根据公司与艾博生物已签署的合作协议，公司同时拥有新冠mRNA疫苗国内市场和国际市场的销售权",
            "features": {
                "keywords": [
                    "沃森生物",
                    "艾博生物",
                    "合作协议",
                    "mRNA疫苗",
                    "销售权"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：根据公司与艾博生物已签署的合作协议，公司同时拥有新冠mRNA疫苗国内市场和国际市场的销售权",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "沃森生物：公司新冠mRNA疫苗在墨西哥的国际多中心三期临床试验各项工作在正常推进中",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA疫苗",
                    "墨西哥",
                    "临床试验"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：公司新冠mRNA疫苗在墨西哥的国际多中心三期临床试验各项工作在正常推进中",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "沃森生物：公司已与艾博生物合作的两个项目均在按计划全力推进",
            "features": {
                "keywords": [
                    "沃森生物",
                    "艾博生物",
                    "合作项目",
                    "全力推进"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：公司已与艾博生物合作的两个项目均在按计划全力推进",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "沃森生物：公司新冠mRNA疫苗目前正在进行国际多中心三期临床试验，各项工作在正常推进中，相关疫苗生产车间已经交付给公司子公司玉溪沃森生物技术有限公司",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA疫苗",
                    "临床试验",
                    "生产车间",
                    "子公司"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：公司新冠mRNA疫苗目前正在进行国际多中心三期临床试验，各项工作在正常推进中，相关疫苗生产车间已经交付给公司子公司玉溪沃森生物技术有限公司",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "沃森生物跌4.68% 中信证券一周前喊买入目标价90元",
            "features": {
                "keywords": [
                    "沃森生物",
                    "中信证券",
                    "目标价",
                    "下跌"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物跌4.68% 中信证券一周前喊买入目标价90元",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "康泰生物、沃森生物、乐普医疗跌超4%，科创创业ETF（588360）跌超1%",
            "features": {
                "keywords": [
                    "康泰生物",
                    "沃森生物",
                    "乐普医疗",
                    "ETF",
                    "下跌"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "康泰生物、沃森生物、乐普医疗跌超4%，科创创业ETF（588360）跌超1%",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "微观流动性跟踪双周报：北上大幅减持钢铁 指数进入压力区域 减持股份",
            "features": {
                "keywords": [
                    "微观流动性",
                    "北上资金",
                    "钢铁",
                    "减持",
                    "压力区域"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "钢铁"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "微观流动性跟踪双周报：北上大幅减持钢铁 指数进入压力区域 减持股份",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-09-14",
            "original_text": "A股融资融券日报：两融余额减少10.55亿元（9月14日）",
            "features": {
                "keywords": [
                    "A股",
                    "融资融券",
                    "两融余额",
                    "减少"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "市场整体"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额减少10.55亿元（9月14日）",
                "Correlation": 2,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        }
    ]
]